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OBJECTIVE: To assess the influence of central obesity on the magnitude of the error of estimate of maximal
oxygen uptake in maximal cycling exercise testing.
METHOD: A total of 1,715 adults (68% men) between 18-91 years of age underwent cardiopulmonary exercise
testing using a progressive protocol to volitional fatigue. Subjects were stratified by central obesity into three
quartile ranges: Q1, Q2-3 and Q4. Maximal oxygen uptake [mL.(kg.min)-1] was estimated by the attained
maximal workload and body weight using gender- and population-specific equations. The error of estimate
[mL.(kg.min)-1] and percent error between measured and estimated maximal oxygen uptake values were com-
pared among obesity quartile ranges.
RESULTS: The error of estimate and percent error differed (mean ± SD) for men (Q1=1.3±3.7 and 2.0±10.4;
Q2-3=0.5±3.1 and -0.5±13.0; and Q4=-0.3±2.8 and -4.5±15.8 (po0.05)) and for women (Q1=1.6±3.3 and
3.6±10.2; Q2-3=0.4±2.7 and -0.4±11.8; and Q4=-0.9±2.3 and -10.0±22.7 (po0.05)).
CONCLUSION: Central obesity directly influences the magnitude of the error of estimate of maximal oxygen
uptake and should be considered when direct expired gas analysis is unavailable.
KEYWORDS: Cardiorespiratory Fitness; Obesity; Cardiopulmonary Exercise Testing; Aerobic Fitness; Body
Composition.
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’ INTRODUCTION
There is strong evidence that cardiorespiratory fitness is
inversely associated with cardiovascular and all-cause mor-
tality (1). Cardiorespiratory fitness can be accurately asses-
sed by directly measuring maximal oxygen consumption
(VO2max) at peak exercise during cardiopulmonary exercise
testing (CPET). However, due to the limited availability of
metabolic testing resources, VO2max is more commonly esti-
mated, rather than directly measured, by applying equations
that take into consideration the maximal workload achieved
or the exercise duration (2,3). Although measured and esti-
mated VO2max are strongly associated, the error of estimate
(EE) for a given subject tends to be substantial, averaging
10-20%, which far exceeds the normal error of other clinical
and laboratory measurements (4).
The ability to utilize oxygen to perform work is related to
an individual’s mechanical efficiency (5). Therefore, when
applying a given equation to estimate VO2max, it is gen-
erally assumed that all subjects have the same mechanical
efficiency, which is biologically incorrect and likely explains
most of the EE of VO2max.
Among the factors that likely influence mechanical effi-
ciency, one of the most clinically relevant is body composi-
tion, primarily due to the increased prevalence of obesity
in recent decades. Obesity and, more particularly, central
obesity may hinder the mobilization of the lower limbs,
possibly reducing the mechanical efficiency for activities
such as cycling or walking (6); therefore, there may be an
increased EE of VO2max in overweight and obese subjects.
Currently, there is very little data available regarding the role
of central obesity as a modulator of the EE of VO2max.
Therefore, the current study was performed to determine
the influence of central obesity, based on the waist to height
ratio (WHtR), in the EE of VO2max.
’ MATERIALS AND METHODS
Sample
Our study population included volunteer adult subjects
in an exercise medicine clinic who initially underwent CPET
using a progressive cycle ergometer protocol between
January 2008 and June 2014. All patients were evaluated
for exercise prescription purposes and provided informed
consent. All patients authorized the de-identified use of
their collected data for research purposes. The study andDOI: 10.6061/clinics/2016(11)02
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retrospective data analysis were approved by the institu-
tional ethics committee. Subjects were excluded based on the
following criteria: those who had previously been tested in
our clinic, those who were younger than 18 years of age,
those who had undergone treadmill testing, and those who
did not fulfill the criteria for a maximal CPET. An addi-
tional 100 subjects who had incomplete data were excluded.
The final population sample included 1,715 subjects.
Anthropometric measurements
Body weight was measured to the nearest 0.1 kg while the
subject was barefoot and wearing light clothing. Height and
waist circumference were obtained to the nearest 0.1 cm. The
latter was measured in the upright position, at the umbilicus
level (7), with an anthropometric tape. The WHtR, obtained
by dividing waist circumference by body height, was used
as an index for central obesity, as it is a more reliable and
proportional measure of obesity than the waist circumference
alone.
Maximal cardiopulmonary exercise testing
Maximal CPET was conducted using an electromagneti-
cally braked cycle ergometer (Inbrasport CG-04, Inbrasport,
Brazil) and an individualized ramp protocol designed to
achieve voluntary exhaustion between 8 and 12 minutes. All
CPET was performed under direct medical supervision in a
properly equipped laboratory. Subject seat height and body
position were carefully adjusted on the cycle ergometer to
provide a comfortable cycling movement. The pedaling rate
was maintained between 65 and 75 revolutions per minute.
One lead CM5 or CC5 digital ECG continuous monitoring
(ErgoPC Elite, Micromed, Brazil) was obtained at rest, during
exercise and at 5-minute recovery periods. Resting, exercise
and post-exercise measurements of heart rate (HR) (bpm)
and blood pressure (mmHg) were obtained from ECG
recordings and by auscultation of the right brachial artery,
respectively.
During CPET, subjects expired through a mouthpiece and
a pneumotachograph Prevent (MedGraphics, United States)
with the nose occluded. Ventilatory analysis was accom-
plished using a metabolic analyzer VO2000 (MedGraphics,
United States) that was calibrated daily. During exercise,
expired gases were continuously collected, and the results
were recorded at 10-second intervals. The data from six
consecutive 10-second intervals were averaged and reported
for each minute during CPET. VO2max represents the highest
oxygen uptake value obtained, expressed as mL.(kg.min)-1,
during CPET.
A CPET session was defined as maximum if it was not
prematurely terminated due to adverse signs/symptoms
and if it fulfilled physiological criteria (8). Additionally,
measures of perceived exertion were obtained to assess
somatic exhaustion, a score of 10 on the 0-10 Borg scale (9),
which was further indicated by the inability to maintain the
required pedal cadence (65-75 rev/min) despite strong ver-
bal encouragement. The highest HR attained was not solely
used as the criterion for considering a CPET session as the
maximum.
Predicting maximum VO2 and HR
To better characterize the study sample, VO2max [mL.(kg.
min)-1] values were predicted by gender-specific equations
(10): 60 - 0.55 x age (years) for men and 48 - 0.37 x age (years)
for women. Maximum values of HR were age-predicted by a
previously validated equation: HR max (bpm) = 208 - 0.7 x
age (years) (11).
Estimating VO2max
VO2max [mL.(kg.min)
-1] was estimated by the gender-
specific equations that were previously validated for a
similar population in our exercise lab as follows: C-MEN =
[maximal workload (watts)/weight (kg)] x 10.79 + 7 and
C-WOMEN = [maximal workload (watts)/weight (kg)] x
9.82 + 7 (12).
Comparing measured and estimated VO2max
To compare measured and estimated VO2max, subjects
were categorized by gender (1,172 men and 543 women) and
then divided into three quartile ranges according to WHtR:
Q1, Q2-3 (combining Q2 and Q3) and Q4. For each of these
quartile ranges, VO2max per kg of body weight, EE
(measured VO2max - estimated VO2max) in mL.(kg.min)
-1
and percent error (%E; [(measured VO2max - estimated
VO2max)/measured VO2max] x 100) were calculated for
both men and women. Negative values of EE and %E
signified that the estimated VO2max was higher than the
measured VO2max, that is, the equation overestimated
VO2max.
Data analysis
Descriptive statistics are presented as mean and standard
deviation or as percent. Demographic characteristics and
CPET variables were compared by t-test or chi-square test for
each gender. Pearson product-moment correlation was also
calculated for measured and estimated VO2max in men and
women. One-way ANOVAwas used to compare EE and %E
among the quartile ranges for each gender. Statistical anal-
ysis was performed using Prism 6 (GraphPad, USA), with
5% probability as the criterion for statistical significance.
’ RESULTS
The average age of our subjects (n=1,715) was 52±
15 years, with men representing 68.3% of the total sample.
Considering the entire study population, 20.8% were appar-
ently healthy, 17.2% had known coronary artery disease, and
the remaining subjects exhibited diverse clinical conditions,
including arterial hypertension, diabetes mellitus, obesity,
pulmonary disease, or combinations thereof. Based on body
mass index (BMI), 41.5% and 23.2% of the subjects were
classified as overweight and obese, respectively, including
1.4% of the total sample that was morbidly obese. Regarding
prescribed medications, 23.0% of the subjects were taking
b-blockers, 34.9% were on angiotensin-converting enzyme
inhibitors or angiotensin II receptor antagonists use, and
39.8% were using cholesterol-lowering medications.
As estimated by the WHtR, central obesity was higher
in men was higher than in women (0.565±0.070 vs. 0.526±
0.082, po0.01). The WHtR results for each of the quartile
ranges for men were as follows: Q1=0.378 to 0.515, Q2-3=
0.515 to 0.612, and Q4=0.612 to 0.900. The WHtR results for
each one of the quartile ranges for women were as follows:
Q1=0.332 to 0.467, Q2-3=0.467 to 0.571, and Q4=0.572 to
0.813. Additional demographic and CPET data, with specific
reference to progressive WHtR ranges, are presented in
Tables 1 and 2.
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Maximal cardiopulmonary exercise testing results
The duration of CPET averaged 10±2 minutes, with 70%
of all tests lasting between 8 and 12 minutes. The maximum
HR, when expressed as a percentage of the age-predicted
value, was similar for men and women (92.2% vs. 93.0%,
respectively, p=0.15). The maximal attained workload was
higher for men than for women (172±70 vs. 111±45 watts,
respectively, po0.01). As a group, men achieved a higher
VO2max than women (29.4±10.5 vs. 24.1±9.0 mL.(kg.min)
-1,
respectively, po0.01). Measured VO2max ranged from 5.8
to 73.3 mL.(kg.min)-1 in men and from 4.1 to 60.1 mL.(kg.
min)-1 in women. For both genders, these values were
consistently lower for those classified in the Q4 cohort of
WHtR (21.9±7.0 the expression ‘‘for men’’ and 16.6±5.1 mL.
(kg.min)-1 the expression ‘‘for women’’, po0.01). Measured
and estimated values of VO2max were strongly correlated in
both sexes (r=0.95, po0.01). For the Q4 subset, the measured
versus estimated VO2max relationship remained highly significant
(r=0.93 and r=0.90 for men and women, respectively) (Figure 1).
Measured VO2max tended to be lower than age-predicted
VO2max, corresponding to 96.6±26.9% and 81.7±24.5% for
men and women, respectively. Considering only Q4 subjects,
measured VO2max corresponded to an even lower percent
of age-predicted VO2max in men and women, 80.0±20.3%
and 64.5±14.4%, respectively.
The values of EE were 0.5±3.2 mL.(kg.min)-1 for men and
0.4±2.9 mL.(kg.min)-1 for women (p=0.54). The values of %E
were 0.9±13.4% for men and -1.8±15.8% for women
(p=0.20). An analysis of %E for the three WHtR quartile
ranges revealed a clear trend, with Q1 showing a slight
Table 1 - Major characteristics and cardiopulmonary exercise testing results according to waist-height ratio ranges (expressed in
quartiles) - men (N=1,172)
Q1 Q2-3 Q4 p value
N 293 586 293
Characteristics
Age (years) 45±14 55±14 58±14 po0.01
Weight (kg) 75.2±9.0 84.8±11.0 98.8±16.4 po0.01
Height (cm) 176.7±6.5* 175.7±6.7* 173.0±7.0 po0.01
Waist/height ratio 0.485±0.024 0.559±0.026 0.658±0.049 po0.01
Predicted VO2max [mL.(kg.min)
-1] 35.3±7.9 29.8±7.6 27.9±7.4 po0.01
Predicted HRmax (bpm) 177±10 170±10 167±9 po0.01
b-blocker usage (%) 15.4 25.1 37.9 po0.01
CPET Results
Duration (min) 11±2 10±2 9±2 po0.01
HRmax (bpm) 170±20 157±25 147±27 po0.01
HRmax measured/predicted (%) 96.2±9.0 92.6±11.9 87.3±13.4 po0.01
Maximum workload (Watts) 208±74 170±65 141±59 po0.01
Measured VO2max [mL.(kg.min)
-1] 37.9±11.0 28.9±8.4 21.9±7.0 po0.01
Measured/predicted VO2max (%) 109.2±28.4 98.7±24.8 80.0±20.3 po0.01
Estimated VO2max [mL.(kg.min)
-1] 36.6±9.9 28.4±7.2 22.2±5.6 po0.01
Error of estimate (EE) [mL.(kg.min)-1] 1.3±3.7 0.5±3.1 -0.3±2.8 po0.01
Percent error (%E) 2.0±10.4# -0.5±13.0# -4.5±15.8 po0.01
*not significant between Q1 and Q2-3 (p=0.15); #p=0.02 between Q1 and Q2-3
Table 2 - Major characteristics and cardiopulmonary exercise testing results according to waist-height ratio ranges (expressed in
quartiles) – women (N=543)
Q1 Q2-3 Q4 p value
N 136 271 136
Characteristics
Age (years) 41±12 51±14 60±14 po0.01
Weight (kg) 57.3±6.8 65.1±8.6 80.3±13.6 po0.01
Height (cm) 165.5±6.4 162.9±6.1 159.2±5.9 po0.01
Waist/height ratio 0.435±0.024 0.514±0.031 0.642±0.054 po0.01
Predicted VO2max [mL.(kg.min)
-1] 32.7±4.4 29.3±5.2 25.7±5.1 po0.01
Predicted HRmax (bpm) 179±8 173±10 166±10 po0.01
b-blocker usage (%) 8.8 14.8 28.1 po0.01
CPET Results
Duration (min) 11±3 9±2 7±2 po0.01
HRmax (bpm) 171±17 164±21 145±26 po0.01
HRmax measured/predicted (%) 95.6±7.5* 94.8±10.1* 87.0±13.1 po0.01
Maximum workload (Watts) 136±47 110±42 86±34 po0.01
Measured VO2max [mL.(kg.min)
-1) 31.9±8.8 24.0±7.2 16.6±5.1 po0.01
Measured/predicted VO2max (%) 98.0±27.2 82.1±21.1 64.5±14.4 po0.01
Estimated VO2max [mL.(kg.min)
-1] 30.2±7.2 23.6±6.0 17.5±3.7 po0.01
Error of estimate (EE) [mL.(kg.min)-1] 1.6±3.3 0.4±2.7 -0.9±2.3 po0.01
Percent error (%E) 3.6±10.2# -0.4±11.8# -10.0±22.7 po0.01
*not significant between Q1 and Q2-3 (p40.99); #p=0.03 between Q1 and Q2-3; p values are for the comparisons among all three groups (Q1, Q2-3 and
Q4) using one-way ANOVA
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tendency to underestimate VO2max and Q4 showing a
strong tendency to overestimate VO2max for both sexes. For
Q4 men, the %E was -4.5±15.8%, which was significantly
larger than the %E for Q1 and Q2-3 (2.0±10.4 and -0.5±
13.0%, respectively, po0.01). For women, an even larger %E
was identified in Q4 (-10.0±22.7%, po0.01), and as observed
in men, comparably lower %E values were seen in Q1 and
Q2-3 (3.6±10.2 and -0.4±11.8%, respectively, po0.01). When
comparing EE and %E by sex in each of the three quartile
ranges, no differences were observed between men and
women (p40.05). Nevertheless, by analyzing the magnitude
of the variability of the EE and %E results, as reflected by the
standard deviation of the means, it is apparent that the EE of
VO2max remained high for any given subject, especially
among those with a higher WHtR.
’ DISCUSSION
Although cardiorespiratory fitness is most accurately
measured during CPET (2), in most cases worldwide,
VO2max is estimated rather than directly measured (4,13),
often resulting in significant errors for any given subject. Our
study addresses this issue by attempting to identify the
impact, if any, of central obesity in the EE of VO2max. This
may be especially relevant in the current era of obesity (6).
While it is reasonable to estimate VO2max, these equations
should be population-specific to account for the specific
features of different populations, including body habitus.
Our study was uniquely focused on reducing the magni-
tude of error in estimating VO2max by considering separate
population-specific equations for men and women. The merit
Figure 1 - Relationship between measured and estimated VO2max: (a) 1,172 men, (b) 543 women, (c) men at Q4 waist-height ratio, and
(d) women at Q4 waist-height ratio.
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of this approach was substantiated by noting that the magni-
tude of EE of VO2max was similar for men and women and
that there were no other significant gender differences related
to VO2max. After having previously developed these equa-
tions (12), in this study, we attempted to evaluate the influence
of another potential modulator, central obesity, on the EE
of VO2max. This was based on the assumption that this var-
iable may adversely decrease mechanical efficiency and,
consequently, increase the EE. In the current analysis, rather
than proposing specific equations that could correct for central
obesity, we focused on analyzing the consistency of these
influences and potential gender differences.
When estimating VO2max from the peak workload
achieved during maximal exercise testing, some variables
may influence the EE, including body composition. First, the
relationship between workload and oxygen consumption
during cycling, that is, the net mechanical efficiency, has been
shown to vary among lean and obese individuals. Hulens
et al. (14) examined differences in exercise capacity in a large
sample of lean and obese women undergoing maximal cycle
ergometer testing. Net mechanical efficiency, calculated as
the ratio between workload and oxygen consumed above
rest to maximal exercise, was lower in women with higher
relative body fat. Similarly, Lafortuna et al. (15) compared
expenditure during cycling in young women of varied body
habitus. Women with higher fat body mass demonstrated
reduced mechanical efficiency, presumably due to the extra
energy required to facilitate the associated body movement.
Anton-Kuchly et al. (16) found that obese men and women
exhibited a higher energy cost during submaximal exercise
than their leaner counterparts, possibly due to the added
energy requirements associated with muscular postural
activity and/or moving the lower extremities.
Another possible explanation for our results is a difference
in resting VO2. As previously described (12), gender-specific
equations used to estimate VO2max assume that all indi-
viduals consume 3.5 mL of oxygen per kg of body weight
per minute at rest. However, subjects with increased fat
mass may have a higher absolute resting VO2 (17). Unfor-
tunately, due to difficulties in establishing a standard-
ized protocol for the accurate measurement of resting VO2
and, therefore, for its use in routine clinical practice (18),
we were unable to quantify this variable in our study.
Previous studies have addressed other variables in obese
individuals that may influence the cardiovascular response
to exercise. Gondoni et al. (19) compared the HR response
to progressive exercise in obese and lean individuals and
reported that obese subjects had a blunted HR response
and a reduced associated exercise tolerance. Fornitano et al.
(20) noted differing clinical, electrocardiographic and hemo-
dynamic responses to conventional exercise testing in morbidly
obese individuals versus their overweight counterparts, rein-
forcing the notion that body composition should be considered
when evaluating exercise performance.
This study has some methodologic features that strengthen
the relevance of our findings. All CPET data were collected
by four physicians in the same clinic, using the same
equipment, under controlled environmental conditions and
having followed standardized criteria for VO2max determi-
nation. The retrospective analysis was undertaken by only
one investigator who was not directly involved in data
collection. The sample size was considerably large and most
likely reflected the clinical profiles typically seen in a
medically based office practice.
There are several limitations of this study that should be
acknowledged. First, age is a potential confounding variable
when considering mechanical efficiency (21). Indeed, there
were significant age differences among our subjects, both
men and women, in the different quartile ranges, with those
categorized in Q4 being significantly older. However, these
subjects also demonstrated low measured VO2max even
when adjusted for age-predicted values, which suggests that
age was not the only variable that contributed to the differ-
ence in mechanical efficiency. Second, subjects were not
specifically evaluated based on the use of different medica-
tions (i.e., -blockers), which may affect mitochondrial
function (22,23), especially in the case of statins, and, in
theory, the measured-estimated VO2max difference. Third,
there are several techniques for categorizing obesity, rang-
ing from more sophisticated approaches, such as computer
tomography and DEXA, to simpler methods, such as bio-
impedance or anthropometric measurements (24). Although
anthropometric measurements are considered somewhat
less precise, they are likely preferable and are considered
reasonably accurate for rapidly evaluating the large number
of subjects encountered during daily clinical practice.
Accordingly, these issues should be considered in the design
of future studies.
Therefore, in agreement with our previous reports (4,12,25),
the application of a single equation to estimate VO2max may
lead to modest errors in some subjects and to significant
errors in others. In our study, the application of a sex-specific
equation identified a distinct magnitude of error when
subjects with higher and lower WHtR were compared. In
subjects with higher central obesity, VO2max values were
systematically overestimated, while the opposite occurred
among subjects with less central obesity, although to a lesser
degree.
Although the aforementioned studies used BMI to
categorize obesity and its relationship to cardiorespiratory
fitness and mechanical efficiency, it is widely recognized that
BMI has numerous limitations in assessing body composi-
tion, because it fails to differentiate body fat from lean mass,
and in providing indices of overall adiposity, fat distribu-
tion and metabolic risk (26-28). Moreover, BMI may be
influenced by age, gender and ethnicity (26), further limiting
its ability to differentiate normal weight, overweight and
obese subjects.
In the present study, the WHtR provided a simple, non-
invasive, anthropometric index to quantify central obesity.
Moreover, unlike BMI, WHtR values are not significantly
influenced by ethnic differences, age and sex, making it
possible to compare central obesity among a heterogeneous
cohort of men and women. Our selection of central obesity
rather than overall obesity as the variable that may influence
mechanical efficiency and the EE of VO2max was based on
recent studies that have demonstrated that fat distribution
has important clinical implications. Because central obesity is
strongly related to visceral fat and increased cardiovascular
risk (29), it seems likely that WHtR is a better prognostic
discriminator than BMI (30,31,32).
In conclusion, central obesity as estimated by the WHtR
influences the magnitude of the EE of VO2max, with a higher
EE in those at the upper end of the WHtR distribution. For
subjects classified in the upper WHtR quartile (men4 0.612
and women 4 0.572), the use of currently available equa-
tions for estimating VO2max may lead to excessive errors
and inaccuracies in clinical practice, especially when using
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functional capacity for risk stratification or in surgical
clearance algorithms.
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